Editor’s Choice

• The global biopharmaceuticals market size is expected to be worth around USD 566 billion by 2032 from USD 263 billion in 2022, growing at a CAGR of 8.2% during the forecast period from 2022 to 2032.
• The overall success rate for phase I trials is around 16%, while for phase II trials it is around 10%. Phase III trials, which involve larger patient populations, have a success rate of around 25%.
• The average cost of bringing a new drug to market is projected to be around USD 2.6 billion.
• The National Genome Institute estimates that the cost of sequencing a human genome has fallen from around USD 100 million in 2001 to less than USD 1,000 in recent years.
• In 2020, WIPO received over 23,500 biotechnology-related patent applications, demonstrating the growing innovation and research in the field.
• The US biotechnology industry employed over 2.1 million people in 2020, including direct and indirect jobs.

(Source: Journal of Clinical Oncology, Journal of Health Economics, World Intellectual Property Organization, Biotechnology Innovation Organization)

Introduction

Biotech Statistics: The biotechnology sector has experienced significant growth, underscored by substantial market valuations and investment activities. In 2023, the global biotechnology market was valued at approximately USD 1.55 trillion and is projected to expand at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. This growth trajectory suggests a market size of around USD 3.88 trillion by 2030.

The United States biotechnology market, specifically, was valued at USD 552.43 billion in 2023 and is anticipated to reach approximately USD 1.79 trillion by 2033, reflecting a CAGR of 12.45% from 2024 to 2033. In 2023, the combined biotechnology industries of the U.S. and Europe secured approximately USD 81.1 billion in capital, encompassing venture capital, initial public offerings (IPOs), follow-on offerings, and debt financing. This robust investment landscape has been instrumental in driving innovation and development within the sector.

These statistics highlight the biotechnology industry's dynamic expansion and its pivotal role in advancing medical and technological innovations globally.

Survey of advanced technology, adoption of biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.

Biotechnology funding by the NIH was around *** billion U.S. dollars during fiscal year 2023. This graph shows the total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2023 and estimates for FY 2024 and FY 2025.

Introduction

Industrial Biotechnology Statistics: Industrial biotechnology is changing industries with inventions that lower environmental impacts, make processes efficient, and make alternatives sustainable. Biotechnology can apply biological systems and even living organisms, whose applications are used in various industries, such as agriculture, environmental management, and healthcare. Majoring in this field becomes important for sustainable solution development and medical innovations.

Biopharmaceuticals, genetic engineering, bioinformatics, and other pieces of synthetic biology are involved in this industry. The following is a detailed study of industrial biotechnology statistics in the year 2024, including growth trends, market valuation, and prospects.

Employment statistics on the Biotechnology industry in the US

In 2020, U.S. biotech companies raised some ten billion U.S. dollars of capital through initial public offerings (IPOs), while they received some 14.2 billion U.S. dollars in risk capital. This statistic contains the financing data of U.S. biotech companies from 2015 to 2020, by type.

Employment statistics on the Global Biotechnology industry in Global

Biotechnology use and development survey, indicators for innovative biotechnology firms by firms size for Canada, biennial survey from 1999 to 2005.

This statistic shows the number of dedicated biotechnology companies based in selected OECD countries for 2022 (or 2023, if available). In 2022, a total of *** dedicated biotechnology companies were operating in Portugal.

Survey of advanced technology, applications related to biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.

Statistics on Biotechnology Use: Researchers in internal R&D activities in Biotechnology por sectors/unit y years. National.

Market Size statistics on the Global Biotechnology industry in Global

Statistics on Biotechnology Use: Research personnel in internal R&D activities in Biotechnology by year and sector/unit. por sectors/unit y years. National.

In 2023, the value of exports from South Korea's biotechnology industry amounted to around **** trillion South Korean won. This represents a decrease from the previous year. Exports within this industry have generally been increasing in recent years.

Abnormal returns statistics: Pharmaceutical vs biotechnology.

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

In 2024, the biotech industry in the U.S. and Europe raised 24.7 billion U.S. dollars in venture capital, the highest amount since 2021. This statistic displays the amount of venture capital raised in the biotechnology industry in the United States and in Europe from 2015 to 2024.

Biotechnology use and development survey, indicators for innovative biotechnology firms for Canada and by region , biennial survey from 1999 to 2005.

Number of Businesses statistics on the Global Biotechnology industry in Global